Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Open in API
Filings indexed 332 across all filing types
Latest filing 2013-02-08 Interim / Quarterly Rep…
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
Half Yearly Report
Interim / Quarterly Report Classification · 1% confidence The document is an 'Interim Results Statement' for Physiomics Plc for the six-month period ended 31 December 2012. It contains substantive financial data, including an unaudited income statement and statement of financial position, as well as management commentary on operational highlights and business strategy. Since it covers a period shorter than a full fiscal year and includes actual financial statements, it is classified as an Interim/Quarterly Report (IR). H1 2013
2013-02-08 English
SEDA Arrangement
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement filed via RNS (RNS Number : 0428W) dated January 22, 2013. The content details the execution of a Standby Equity Distribution Agreement (SEDA) for £4 million and the subsequent issue of 8,000,000 Ordinary Shares to satisfy an initial payment. This transaction directly relates to financing activities, capital structure changes, and the issuance of new equity. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). While it is an RNS filing, the specific subject matter is highly indicative of CAP, which takes precedence over the general RNS fallback.
2013-01-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.